Home > In Development > Medication-related Osteonecrosis of the Jaw

Oral Health Management of Patients Prescribed Anti-resorptive or Anti-angiogenic Drugs

Consultation ended 1stBP bone October 2016

The consultation on draft guidance Oral Health Management of Patients Prescribed Anti-resorptive or Anti-angiogenic Drugs is now closed. Thank you to all who contributed to this process.

The guidance, which is an update to the 2011 SDCEP publication Oral Health Management of Patients Prescribed Bisphosphonates and includes new advice on the wider range of drugs implicated in medication-related osteonecrosis of the jaw (MRONJ), will be published in due course.

The aim of the updated guidance is to provide clear and practical advice for dentists in primary care on how to provide care for patients prescribed these drugs.  The guidance will also be of relevance to prescribers and dispensers of the drugs and to patients.

Guidance Development Group

A Guidance Development Group comprising individuals from a range of branches of the dental profession and other disciplines and two patient representatives was convened to draft this guidance.

Name Position
Michaelina Macluskey
(Co-Chair)
Senior Lecturer/Honorary Consultant Oral Surgeon, Dundee Dental Hospital and School
Stephanie Sammut
(Co-Chair)
Consultant in Oral Surgery, Dundee Dental Hospital and School
Jan Clarkson Professor of Clinical Effectiveness, Dundee Dental Hospital and School; SDCEP Programme Director
Alexander Crighton Consultant in Oral Medicine, University of Glasgow Dental Hospital and School
Helen Devennie Specialist Practitioner (Medically Compromised and Oral Surgery), Inverness Dental Centre
Elizabeth Foster Patient Representative
Karen Gordon Consultant in Special Care Dentistry, Edinburgh
Duncan Gowans Consultant Haematologist, Ninewells Hospital, Dundee; Perth Royal Infirmary
Vicki Greig Scottish Clinical Leadership Fellow
Doris Hunter Patient Representative
Douglas Kennedy Consultant in Oral & Maxillofacial Surgery, NHS Tayside
Pamela Kidd General Dental Practitioner, Glasgow
Penny Lockwood General Medical Practitioner, Dundee; Honorary Senior Lecturer, University of Dundee
Nick Malden Consultant in Oral Surgery, Edinburgh Dental Institute
Anna Macdonald Senior Dental Officer, Specialist in Special Care Dentistry, Perth
Margaret Mooney Administrator, Scottish Dental Clinical Effectiveness Programme
Gillian Nevin General Dental Practitioner, Coupar Angus; Assistant Director of Postgraduate GDP Education, Dundee Dental Education Centre
Terence O’Neill Professor of Rheumatology and Clinical Epidemiology, University of Manchester; Member of Clinical & Scientific Committee, National Osteoporosis Society
David Reid Emeritus Professor of Rheumatology, University of Aberdeen
Samantha Rutherford Research and Development Manager, Scottish Dental Clinical Effectiveness Programme
Doug Stirling Programme Manager, Scottish Dental Clinical Effectiveness Programme
Andrew Wight General Dental Practitioner, Dundee
Linda Young Research and Development Manager – Evaluation of Implementation, Scottish Dental Clinical Effectiveness Programme